Passive digital health nQ Medical specializes in passive, 24/7 monitoring of neurodegenerative trajectories through analysis of user-device interactions, offering a compelling value proposition for CROs and sponsors seeking real-world data and continuous endpoints without patient burden.

Remote trial enablement The company supports remote, online recruitment and at‑home disease staging, enabling faster enrollment, broader participant reach, and unbiased real-world data—a strong fit for sponsors aiming to shorten trial timelines and improve population representation.

PD management platform nQ’s Mobile PD Management Platform can augment outpatient treatment by enabling clinical titration, therapy measurement, patient engagement, and caregiver observation, presenting a packaged solution for life-cycle management of neurodegenerative therapies.

Strategic partnerships Collaborations with Fleksy and health foundations signal an ecosystem approach, suggesting potential co‑selling opportunities with device partners and patient advocacy groups to expand reach and adoption.

AI and data edge Leveraging machine learning and sensors to detect subtle neurodegenerative changes on common devices positions nQ Medical as a data and analytics partner for trials seeking early signals, stratification, and real-world endpoints, appealing to sponsors prioritizing precise, early impact measures.